A Scientist’s Seven-Year Odyssey To Commercialize His Drug, By Trial And (A Lot Of) Error
It wasn’t for social reasons that Dr. Jeff Toretsky became a regular at mixers in suburban Maryland.
The mixers were for the region’s sparse biotech community and Toretsky, a researcher and physician at Georgetown University, was on the prowl for a CEO to help commercialize a molecule his lab discovered.
It’s a story that’s hardly unique in biomedicine: Academic develops a drug, forms a tiny company, carries out human trials, maybe even cashes out when the company gets bought. Boston, New York, and San Francisco are awash with companies that started this way.
The mixers were for the region’s sparse biotech community and Toretsky, a researcher and physician at Georgetown University, was on the prowl for a CEO to help commercialize a molecule his lab discovered.
It’s a story that’s hardly unique in biomedicine: Academic develops a drug, forms a tiny company, carries out human trials, maybe even cashes out when the company gets bought. Boston, New York, and San Francisco are awash with companies that started this way.